首页> 中文期刊> 《世界核心医学期刊文摘:眼科学分册》 >使用Ex-PRESS微型青光眼植入物治疗晚期青光眼的疗效争论:一项临床前导性研究

使用Ex-PRESS微型青光眼植入物治疗晚期青光眼的疗效争论:一项临床前导性研究

         

摘要

To report results of implantation of the Ex-PRESS Miniature Glaucoma Implant (Optonol, Neve Ilan, Israel) shunt directly under the conjunctiva in advanced gl aucoma. Noncomparative case series. Chart review of eleven cases of Ex-PRESS im plantation. Outcome measures included intraocular pressure (IOP), complications, visual acuity, and additional interventions. Failure was defined as unacceptabl y high IOP requiring revision or explantation. Four patients (36%) failed. Ten (91%) experienced hypotony during postoperative week one. In the seven nonfailu res, mean pre and postoperative IOPs were 30.3 ±9.3 mm Hg and 13.6 ±4.4 mm Hg, respectively (P=. 006). The logMAR visual acuity did not change significantly f rom baseline to follow up (logMAR 1.1 ±0.9 and 1.4 ±0.9, respectively, P=. 13) . There were no intraoperative complications. Postoperative complications in the 11 eyes included choroidal detachment in 3 (27%) and suprachoroidal hemorrhage in 2 (18%). Of the 7 successful cases, additional interventions were required in 4 (57%). Despite significant IOP reduction, the incidence of complications f ollowing Ex-PRESS implantation directly under the conjunctiva was unacceptably high in this group of patients.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号